Proactive Investors - Run By Investors For Investors

Physiomics hails the potential of new alliance

It is joining a network of advisors brought together by Medicines Discovery Catapult, which is charged with supporting innovation in the drugs sector
woman at microscope
The company has developed technology that improves R&D success rates

Physiomics Plc (LON:PYC) said it was excited to be striking up new relationships in the world of oncology after inking a strategic collaboration.

It is joining a network of advisors brought together by Medicines Discovery Catapult (MDC), which is charged with supporting innovation in the drugs sector.

READ: Physiomics extends lucrative relationship with Merck

Physiomics for its part brings with it cutting-edge technology such as its virtual tumour software, which is used to predict the effect of cancer drugs that in turn helps improve R&D success rates.

As part of the tie-up with the MDC, the company will be introduced to “selected potential clients and in return will receive a small commission on the value of any service contracts arising from such introductions”.

Chief executive, Dr Jim Millen, said: "We are delighted to be working with the MDC, an organisation that plays such a key role in supporting emerging biotech companies in the UK.

“We're also excited by the potential that this new relationship offers to connect Physiomics to emerging players in the field of oncology."

In late morning trading, shares in Physiomics were 5.3% higher at 3.95p.

 -- Adds share price --

View full PYC profile View Profile

Physiomics Plc Timeline

Related Articles

test tubes
May 07 2019
Here we take a closer look at Arix Biosciences PLC (LON:ARIX), a listed venture capital company that doesn’t appear to be receiving the recognition it deserves
Pictured is the company's myLotus test
May 15 2019
Here we take a closer look at testing firm Concepta PLC (LON:CPT)
Sativa
June 07 2019
Geremy Thomas, founder and chief executive of Sativa, said the company has "delivered expeditiously on its investment promise to the market"

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use